The stock is in a sustained uptrend over the past year, evidenced by a 1-year price change of +15.34%, but is currently experiencing a significant pullback from its recent highs. As of the latest close at $112.21, the stock is trading at approximately 35% of its 52-week range, positioned much closer to its 52-week low of $80.69 than its high of $133.99, suggesting the momentum has reversed and the stock is now in a corrective phase, potentially offering a value opportunity if the fundamentals remain intact. Recent momentum has turned sharply negative, with the stock down -5.04% over the past month and -14.11% over the past three months, a stark divergence from the positive 1-year and 6-month (+28.23%) trends, signaling a potential trend reversal or a deep correction within the longer-term uptrend. The stock's beta of 1.33 indicates it is 33% more volatile than the broader market, which has compounded the recent downside, as seen in its -21.84% 3-month relative strength versus the SPY. Key technical levels are clearly defined, with major support at the 52-week low of $80.69 and resistance at the recent high of $133.99; a breakdown below the $100 psychological level and the March low near $98 could accelerate selling, while a recovery above the $130 resistance area would signal a resumption of the primary uptrend.

Revenue growth is robust and accelerating, with Q4 2025 revenue reaching $2.10 billion, representing a 17.58% year-over-year increase, and sequential quarterly revenue has grown from $1.22 billion in Q1 to $2.10 billion in Q4, indicating strong demand momentum. The company is solidly profitable, with Q4 2025 net income of $255.2 million and a net margin of 12.14%, while gross margin for the quarter was a healthy 47.95%; profitability has improved significantly year-over-year, as the Q4 2024 net margin was only 7.20%, demonstrating effective margin expansion. The balance sheet is healthy with a strong current ratio of 2.04 and a moderate debt-to-equity ratio of 0.34, indicating good liquidity and manageable leverage; however, trailing twelve-month free cash flow is negative at -$42.0 million, suggesting recent growth investments or working capital needs have consumed cash, though the latest quarterly operating cash flow was a strong $587.1 million.